Does Medical Marijuana, Inc. (MJNA) own Dixie Elixirs?

One of the biggest misconceptions in the cannabis investing sector is the belief that Medical Marijuana, Inc. (MJNA) acquired the Colorado-based Dixie Elixirs & Edibles in 2012.  Nothing could be further from the truth.  If you already know this, then there is no need to continue.  But, if you have any question about the relationship between MJNA and Dixie, read on.

First, don't blame yourself if you were confused.  I don't want to accuse MJNA of fooling people on purpose, but there were many times when they blew smoke to obfuscate the reality.  I described this earlier this year in a Seeking Alpha post.   So what's the real deal?

MJNA created a subsidiary called "Red Dice Holdings",  which is 60% owned by MJNA and 40% by Left Bank LLC (dba Dixie Elixirs & Edibles).  MJNA kicked in $1.45mm, while Left Bank contributed the brand (Dixie) and intellectual property.  The deal was described in an OTC Markets disclosure for Q2-2012: 

Sorry that this is crooked, but this is the lame way MJNA was doing its disclosures.  Thankfully, they progressed from using a scan!  

So, Red Dice Holdings licenses the brand.  The big question, and this Cannabis Financial Analyst doesn't know the answer, is this:  Will MJNA benefit from Colorado THC sales ever?  This is very important, as Dixie Elixirs is obviously doing very well in Colorado, but MJNA shareholders don't benefit at all.  My guess is that they never will, as the deal was struck to take advantage of new markets.  Even there, Dixie has been pretty clear that it isn't benefiting at all from THC yet.  Why not?  A year and a half after the deal, despite the fact that 20 states have adopted medical marijuana, Red Dice hasn't recognized a single penny in THC revenues.

So, the bottom-line:  MJNA does NOT own Dixie Elixirs & Edibles.  Instead, it is a partner through Red Dice Holdings, which allowed them to realize all of $156K in sales in Q2, which included only the web-based sales of Dixie Botanicals CBD products.  The $64K question is when and to what extent MJNA can recognize THC sales. The other interesting angle is that MJNA subsidiary HempMedsPx will be launching competing products (manufactured by CannaVest) shortly, as I explained in this post .

Special Offer

One of the key benefits to subscribers of 420Investor  is access to industry leaders.  I have been fortunate to have tapped into a huge network of people involved with the public companies as well as private companies or academiia. I will, of course, be sharing information with subscribers, whether it is quick comments or exclusive interviews, but I have a bunch of really dynamic people who have agreed to spend time in live presentations as well.

We will be kicking this off on October 1st at 6PM EST, and I have to admit that it may be difficult to top our first guest, Jamen Shively, founder of Diego Pellicer.   In case you aren't familiar with him, he has very ambitious plans ...

Read More

New Reverse Merger In Cannabis Space Worth Getting To Know

Earlier this week, I was approached by Paul Rosenberg, CEO of mCig, which recently reverse merged with Lifetech Industries.  He was impressed with my interview of Sterling Scott   CEO of GrowLife (PHOT), and wanted to tell me his story ...

Read More

Bankrate - Pot Stocks: Don't Do Drug Scams

I was quoted in a recent article examining the FINRA warning on pot stocks:

"That is the message of FINRA: Be careful. There are people out there that are focused on marijuana stocks because they are hot," says Alan Brochstein ...

Read More

Pre-Launch of 420 Investor

If you are like me and think that the rapidly changing regulatory landscape and public opinion about marijuana will unleash tremendous investment opportunities, then you want to understand the players, the challenges they face and the potential rewards to those ...

Read More

Reviews Average Rating          

Great content. Information provided is accurate and timely. It’s very well written with with thorough analysis.
Alan (420 Investor) is a great source of timely information on the cannabis sector. While I'm not a short term trader I still enjoy his short term updates as it keeps me connected to market. I'm ho...
See All Reviews →